Skip to content
    Action Potential Venture Capital logo

    Action Potential Venture Capital

    Cambridge, Massachusetts, United StatesFounded 2013
    actionpotentialvc.comLinkedIn
    Healthcare

    Action Potential Venture Capital (APVC) is a medical technology venture capital firm founded by GlaxoSmithKline (GSK) that focuses on advancing bioelectronic medicines and enabling technologies. The firm invests in early to growth-stage companies developing novel devices or platforms that interface with the peripheral nervous system to treat chronic diseases.

    100% of their portfolio is in Healthcare. Their most common stage is series-b (40% of deals). Average disclosed round size is $50.8M (across 5 rounds with reported amounts).

    Find people at Action Potential Venture Capital on Goldilocks AI

    Portfolio

    5

    Fund Size

    $50M

    Top Stage

    Series B

    Last 12 Mo

    1

    Portfolio Breakdown

    Stage Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    5 investments
    CompanyRoundAmountDate
    Alpheus Medical, Inc. logoAlpheus Medical, Inc.Series B$52MMay 2025
    Cala Health logoCala HealthGrowth$50MDec 2024
    MicroTransponder logoMicroTransponderSeries E$73MSep 2022
    MicroTransponder logoMicroTransponderSeries E$53MJun 2022
    Neuspera Medical logoNeuspera MedicalSeries B$26MFeb 2019

    Top Co-Investors

    U.S. Venture Partners2 shared
    Osage University Partners2 shared
    The Vertical Group2 shared
    HealthQuest Capital1 shared
    Samsara BioCapital1 shared
    OrbiMed1 shared
    BrightEdge1 shared
    Brain Tumor Investment Fund1 shared
    Windham Venture Partners1 shared
    GPG Ventures1 shared
    Exceller Hunt Ventures1 shared
    Lux Capital1 shared
    GV (Google Ventures)1 shared
    Vertex Growth Fund1 shared
    Nexus NeuroTech Ventures1 shared
    Lightstone Ventures1 shared
    Ascension Ventures1 shared
    TriVentures1 shared
    Peak6 Strategic Capital1 shared

    Last updated: 8 March 2026